HomeInsights52 Week Low Stocks

Dr Reddys Laboratories Ltd 52 Week Low

Dr Reddys Laboratories Ltd 52 Week Low

stocks purchased

₹ 27.7 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

206.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

YEARLOW

₹ 1094.88

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week Low of Dr Reddys Laboratories Ltd is ₹ 1094 as of 20 Dec 24 .

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20241342.45
19 Dec 20241326
18 Dec 20241275.05
17 Dec 20241248
16 Dec 20241269.9
13 Dec 20241246.3
12 Dec 20241245.95
11 Dec 20241238.45
10 Dec 20241239.95
09 Dec 20241254.8

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories allots 13,080 equity shares under ESOS

Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...

Read more

20 Dec 2024 09:31

News

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

Read more

20 Dec 2024 13:05

News

Dr Reddys launches immuno-oncology drug - Toripalimab in India

Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...

Read more

28 Nov 2024 09:14

News

Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India

Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...

Read more

28 Nov 2024 10:11

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 2024 10:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 2024 10:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Dr Reddys Laboratories Ltd

Why is it important to track the 52-week low of Dr Reddys Laboratories Ltd stocks?

Investors should monitor the 52-week low of Dr Reddys Laboratories Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Dr Reddys Laboratories Ltd stocks hitting a 52-week low?

Factors leading to Dr Reddys Laboratories Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Dr Reddys Laboratories Ltd stocks when they hit a 52-week low?

Buying Dr Reddys Laboratories Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Dr Reddys Laboratories Ltd stocks?

Investors should monitor the 52-week low of Dr Reddys Laboratories Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Dr Reddys Laboratories Ltd stock at their 52-week low?

An investor can analyze the reasons for the Dr Reddys Laboratories Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Dr Reddys Laboratories Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Dr Reddys Laboratories Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Dr Reddys Laboratories Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions